A. Atmaca, M. Ahn, A. Lisberg, L. Paz-Ares, R. Cornelissen, N. Girard, E. Pons-Tostivint, D. Baz, S. Sugawara, M. Cobo, M. Pérol, C. Mascaux, E. Poddubskaya, S. Kitazono, H. Hayashi, J. Sands, R. Hall, Y. Zhang, H. Zebger-Gong, I. Okamoto, C. Schumann
{"title":"对既往接受过治疗的晚期/转移性(adv/met)非小细胞肺癌(NSCLC)进行的 Datopotamab deruxtecan(Dato-DXd)与多西他赛对比研究:随机3期研究TROPION-Lung01的结果","authors":"A. Atmaca, M. Ahn, A. Lisberg, L. Paz-Ares, R. Cornelissen, N. Girard, E. Pons-Tostivint, D. Baz, S. Sugawara, M. Cobo, M. Pérol, C. Mascaux, E. Poddubskaya, S. Kitazono, H. Hayashi, J. Sands, R. Hall, Y. Zhang, H. Zebger-Gong, I. Okamoto, C. Schumann","doi":"10.1055/s-0044-1781395","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517930,"journal":{"name":"64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.","volume":"75 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase 3 study TROPION-Lung01\",\"authors\":\"A. Atmaca, M. Ahn, A. Lisberg, L. Paz-Ares, R. Cornelissen, N. Girard, E. Pons-Tostivint, D. Baz, S. Sugawara, M. Cobo, M. Pérol, C. Mascaux, E. Poddubskaya, S. Kitazono, H. Hayashi, J. Sands, R. Hall, Y. Zhang, H. Zebger-Gong, I. Okamoto, C. Schumann\",\"doi\":\"10.1055/s-0044-1781395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517930,\"journal\":{\"name\":\"64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.\",\"volume\":\"75 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0044-1781395\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1781395","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase 3 study TROPION-Lung01